Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Omer Onur Cakir, Division of Surgery and Interventional Science
  • ,
  • Fabio Castiglione, Royal Free Hospital/University College London Hospital, London, UK.
  • ,
  • Zafer Tandogdu, Division of Surgery and Interventional Science
  • ,
  • Justin Collins, Division of Surgery and Interventional Science
  • ,
  • Hussain M Alnajjar, Royal Free Hospital/University College London Hospital, London, UK.
  • ,
  • Clare Akers, Royal Free Hospital/University College London Hospital, London, UK.
  • ,
  • Maarten Albersen, Leuven Centre for Algology & Pain Management, University Hospitals Leuven, University Hospitals Leuven, Pellenberg, Belgium.
  • ,
  • Constantine Alifrangis, Queen Marys Univ London, Queen Mary University London, University of London, Barts & London Sch Med & Dent
  • ,
  • Benjamin Ayres, St George's University Hospitals NHS Foundation Trust
  • ,
  • Oscar Brouwer, Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • ,
  • Ivor Cullen, Cancer Trials Ireland and University Hospital Waterford, Ireland.
  • ,
  • Peter Hawkey, Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • ,
  • Jakob Kristian Jakobsen
  • Truls Erik Bjerklund Johansen
  • Odunayo Kalejaiye, University Hospitals Birmingham, Birmingham, UK.
  • ,
  • Asheesh Kaul, Norwich Medical School University of East Anglia and Norfolk and Norwich University Hospital, Norwich, UK.
  • ,
  • Bela Köves, Department of Urology, South Pest Teaching Hospital
  • ,
  • Vivekanandan Kumar, Norwich Medical School University of East Anglia and Norfolk and Norwich University Hospital, Norwich, UK.
  • ,
  • Mariangela Mancini, Univ Padua, University of Padua, Dept Biol
  • ,
  • Anita Vanessa Mitra, Royal Free Hospital/University College London Hospital, London, UK.
  • ,
  • Arie Parnham, Department of Urology
  • ,
  • Edoardo Pozzi, Københavns Universitet
  • ,
  • Chris Protzel, Helios Kliniken Schwerin Medical School MSH
  • ,
  • Vijay K Sangar, Centre for Mental Health and Safety, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; NIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, UK; Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.
  • ,
  • Florian Wagenlehner, Justus Liebig Univ, Justus Liebig University Giessen, Dept Physiol
  • ,
  • Asif Muneer, NIHR Biomedical Research Centre

OBJECTIVES: To develop an international consensus on managing penile cancer patients during the COVID-19 acute waves. A major concern for patients with penile cancer during the coronavirus disease 2019 (COVID-19) pandemic is how the enforced safety measures will affect their disease management. Delays in diagnosis and treatment initiation may have an impact on the extent of the primary lesion as well as the cancer-specific survival because of the development and progression of inguinal lymph node metastases.

MATERIALS AND METHODS: A review of the COVID-19 literature was conducted in conjunction with analysis of current international guidelines on the management of penile cancer. Results were presented to an international panel of experts on penile cancer and infection control by a virtual accelerated Delphi process using 4 survey rounds. Consensus opinion was defined as an agreement of ≥80%, which was used to reconfigure management pathways for penile cancer.

RESULTS: Limited evidence is available for delaying penile cancer management. The consensus rate of agreement was 100% that penile cancer pathways should be reconfigured, and measures should be developed to prevent perioperative nosocomial transmission of COVID-19. The panel also reached a consensus on several statements aimed at reconfiguring the management of penile cancer patients during the COVID-19 pandemic.

CONCLUSIONS: The international consensus panel proposed a framework for the diagnostic and invasive therapeutic procedures for penile cancer within a low-risk environment for COVID-19.

OriginalsprogEngelsk
TidsskriftUrologic Oncology: Seminars and Original Investigations
Vol/bind39
Nummer3
Sider (fra-til)197.e9-197.e17
ISSN1078-1439
DOI
StatusUdgivet - mar. 2021

Se relationer på Aarhus Universitet Citationsformater

ID: 210546962